{"issuance_frequency":"","notes_translated":{"fr":"Le Relevé des maladies transmissibles au Canada est une publication bilingue et libre d'accès revue par un comité de lecture portant sur la prévention et le contrôle des maladies infectieuses nouvelles et tenaces.\r\n","en":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases. \r\n"},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"unknown","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"6ca86aab-385e-4ea8-b61b-6092602ecdfc","metadata_created":"2018-12-06T17:11:15.174472","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2018-12-06T17:11:15.174480","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2018-12-06","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["La résistance au antimicrobiens","l’approche « Une Santé »","Utilisation des antimicrobiens","Gestion","Agriculture","Agroalimentaire","Recherche","Surveillance","Expositions en laboratoire","Pathogènes","Toxines","Humains","Canada","Antituberculeux","Guide","Pratiques d'administration","Vaccins","Immunisation","Hépatite A","Infection par le virus","Utilisation du Cannabis","Antimicrobiens."],"en":["Antimicrobial resistance","Antimicrobial use","One Health","Tuberculosis","Stewardship","Agriculture","Agri-food","Research","Surveillance","Laboratory Exposure","Human","Pathogens","Toxins","Canada","Guide","Vaccine","Administration practice","Immunization","Hepatitis A","virus infection","Cannabis use","Antimicrobial."]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"RMTC : Volume 43-11, le 2 novembre 2017 : La résistance au antimicrobiens et l’approche « Une Santé »","en":"CCDR: Volume 43-11, November 2, 2017: Antimicrobial resistance and One Health"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"6ca86aab-385e-4ea8-b61b-6092602ecdfc","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"ca8eb6c4-71f1-4f45-8571-9610806f0760","related_relationship":"","name_translated":{"fr":"RMTC : Volume 43-11, le 2 novembre 2017 : La résistance au antimicrobiens et l’approche « Une Santé »","en":"CCDR: Volume 43-11, November 2, 2017: Antimicrobial resistance and One Health"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 43-11, November 2, 2017: Antimicrobial resistance and One Health","language":["en"],"created":"2018-12-06T17:11:16.222060","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-11-november-2-2017/ccdr-43-11-onehealth-eng.pdf","last_modified":null,"position":0,"revision_id":"a5c0f707-89f4-48ed-a454-0ae4f84f986d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ca86aab-385e-4ea8-b61b-6092602ecdfc","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"c9a143bc-fd95-4937-9f46-6eaf089e7a85","related_relationship":"","name_translated":{"fr":"RMTC : Volume 43-11, le 2 novembre 2017 : La résistance au antimicrobiens et l’approche « Une Santé »","en":"CCDR: Volume 43-11, November 2, 2017: Antimicrobial resistance and One Health"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 43-11, November 2, 2017: Antimicrobial resistance and One Health","language":["fr"],"created":"2018-12-06T17:11:16.222070","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-11-november-2-2017/rmtc-43-11-unesante-fra.pdf","last_modified":null,"position":1,"revision_id":"a5c0f707-89f4-48ed-a454-0ae4f84f986d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ca86aab-385e-4ea8-b61b-6092602ecdfc","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"082b2f18-1ed8-43c1-8b05-f041c4534f22","related_relationship":"","name_translated":{"fr":"Cadre de travail canadien sur la résistance aux antimicrobiens et l’utilisation des antimicrobiens","en":"Pan-Canadian framework for action on antimicrobial resistance and antimicrobial use"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Pan-Canadian framework for action on antimicrobial resistance and antimicrobial use","language":["en"],"created":"2018-12-06T17:11:16.222074","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-11-november-2-2017/pan-canadian-framework-action-antimicrobial-resistance.html","last_modified":null,"position":2,"revision_id":"a5c0f707-89f4-48ed-a454-0ae4f84f986d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ca86aab-385e-4ea8-b61b-6092602ecdfc","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"fc8c4990-3b7e-4455-852c-77e26c3fdade","related_relationship":"","name_translated":{"fr":"Cadre de travail canadien sur la résistance aux antimicrobiens et l’utilisation des antimicrobiens","en":"Pan-Canadian framework for action on antimicrobial resistance and antimicrobial use"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Pan-Canadian framework for action on antimicrobial resistance and antimicrobial use","language":["fr"],"created":"2018-12-06T17:11:16.222077","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-11-2-novembre-2017/cadre-action-pancanadien-resistance-antimicrobiens-utilisation-antimicrobiens.html","last_modified":null,"position":3,"revision_id":"a5c0f707-89f4-48ed-a454-0ae4f84f986d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ca86aab-385e-4ea8-b61b-6092602ecdfc","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"2508286d-11cd-471c-8755-2199cca2f7d3","related_relationship":"","name_translated":{"fr":"Gestion des antimicrobiens et réglementation des médicaments vétérinaires","en":"Antimicrobial stewardship and veterinary drug regulation"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Antimicrobial stewardship and veterinary drug regulation","language":["en"],"created":"2018-12-06T17:11:16.222080","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-11-november-2-2017/enhancing-antimicrobial-stewardship-strengthening-veterinary-drug-regulatory-framework.html","last_modified":null,"position":4,"revision_id":"a5c0f707-89f4-48ed-a454-0ae4f84f986d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ca86aab-385e-4ea8-b61b-6092602ecdfc","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"4873ccbd-ba9f-4b15-b3db-b9fd50cac4c8","related_relationship":"","name_translated":{"fr":"Gestion des antimicrobiens et réglementation des médicaments vétérinaires","en":"Antimicrobial stewardship and veterinary drug regulation"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Antimicrobial stewardship and veterinary drug regulation","language":["fr"],"created":"2018-12-06T17:11:16.222083","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-11-2-novembre-2017/amelioration-gestion-antimicrobiens-renforcement-cadre-reglementation-medicaments-veterinaires.html","last_modified":null,"position":5,"revision_id":"a5c0f707-89f4-48ed-a454-0ae4f84f986d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ca86aab-385e-4ea8-b61b-6092602ecdfc","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"6d3f36ec-6f19-42fb-91db-c96f7226c2fa","related_relationship":"","name_translated":{"fr":"Recherche d’Agriculture et Agroalimentaire Canada sur la résistance aux antimicrobiens","en":"Agriculture and Agri-Food Canada: antimicrobial resistance "},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Agriculture and Agri-Food Canada: antimicrobial resistance ","language":["en"],"created":"2018-12-06T17:11:16.222086","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-11-november-2-2017/agriculture-agri-food-canada-research-program-antimicrobial-resistance.html","last_modified":null,"position":6,"revision_id":"a5c0f707-89f4-48ed-a454-0ae4f84f986d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ca86aab-385e-4ea8-b61b-6092602ecdfc","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"31e9ad2a-dd66-4ad2-b939-6a7fca4f65dc","related_relationship":"","name_translated":{"fr":"Recherche d’Agriculture et Agroalimentaire Canada sur la résistance aux antimicrobiens","en":"Agriculture and Agri-Food Canada: antimicrobial resistance "},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Agriculture and Agri-Food Canada: antimicrobial resistance ","language":["fr"],"created":"2018-12-06T17:11:16.222088","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-11-2-novembre-2017/programme-recherche-agriculture-agroalimentaire-canada-resistance-antimicrobiens.html","last_modified":null,"position":7,"revision_id":"a5c0f707-89f4-48ed-a454-0ae4f84f986d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ca86aab-385e-4ea8-b61b-6092602ecdfc","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"55d0478f-4b87-4abf-b1fb-4f4b3fb15a3a","related_relationship":"","name_translated":{"fr":"Expositions en laboratoire aux agents pathogènes humains et aux toxines au Canada","en":"Laboratory exposures to human pathogens and toxins in Canada"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Laboratory exposures to human pathogens and toxins in Canada","language":["en"],"created":"2018-12-06T17:11:16.222091","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-11-november-2-2017/surveillance-laboratory-exposures-human-pathogens-toxins-canada-2016.html","last_modified":null,"position":8,"revision_id":"a5c0f707-89f4-48ed-a454-0ae4f84f986d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ca86aab-385e-4ea8-b61b-6092602ecdfc","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"1082433e-2962-4071-9951-47cf3bc7d350","related_relationship":"","name_translated":{"fr":"Expositions en laboratoire aux agents pathogènes humains et aux toxines au Canada","en":"Laboratory exposures to human pathogens and toxins in Canada"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Laboratory exposures to human pathogens and toxins in Canada","language":["fr"],"created":"2018-12-06T17:11:16.222094","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-11-2-novembre-2017/surveillance-expositions-laboratoire-agents-pathogenes-humains-toxines-canada-2016.html","last_modified":null,"position":9,"revision_id":"a5c0f707-89f4-48ed-a454-0ae4f84f986d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ca86aab-385e-4ea8-b61b-6092602ecdfc","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"4adc8e2d-b2a1-46bf-9a27-64868b885d48","related_relationship":"","name_translated":{"fr":"La résistance aux antituberculeux au Canada","en":"Tuberculosis drug resistance in Canada"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Tuberculosis drug resistance in Canada","language":["en"],"created":"2018-12-06T17:11:16.222096","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-11-november-2-2017/tuberculosis-drug-resistance-canada-2006-2016.html","last_modified":null,"position":10,"revision_id":"a5c0f707-89f4-48ed-a454-0ae4f84f986d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ca86aab-385e-4ea8-b61b-6092602ecdfc","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"9fc29f24-57df-4cc7-80ae-3c2853fd2994","related_relationship":"","name_translated":{"fr":"La résistance aux antituberculeux au Canada","en":"Tuberculosis drug resistance in Canada"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Tuberculosis drug resistance in Canada","language":["fr"],"created":"2018-12-06T17:11:16.222099","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-11-2-novembre-2017/resistance-antituberculeux-canada-2006-2016.html","last_modified":null,"position":11,"revision_id":"a5c0f707-89f4-48ed-a454-0ae4f84f986d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ca86aab-385e-4ea8-b61b-6092602ecdfc","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"b97d55c6-b972-4dbd-988b-ebfcf96a7c71","related_relationship":"","name_translated":{"fr":"Évolution de la résistance aux antituberculeux au Canada. : données supplémentaires","en":"TB drug resistance in Canada: Supplementary data"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"TB drug resistance in Canada: Supplementary data","language":["en"],"created":"2018-12-06T17:11:16.222102","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-11-november-2-2017/tuberculosis-drug-resistance-canada-2006-2016-supplementary-data.html","last_modified":null,"position":12,"revision_id":"a5c0f707-89f4-48ed-a454-0ae4f84f986d","resource_type":"dataset"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ca86aab-385e-4ea8-b61b-6092602ecdfc","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"bbf2e1c5-9f71-44c5-9cc6-0f9bf6f281cb","related_relationship":"","name_translated":{"fr":"Évolution de la résistance aux antituberculeux au Canada. : données supplémentaires","en":"TB drug resistance in Canada: Supplementary data"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"TB drug resistance in Canada: Supplementary data","language":["fr"],"created":"2018-12-06T17:11:16.222104","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-11-2-novembre-2017/resistance-antituberculeux-canada-donnees-supplementaires-2006-2016.html","last_modified":null,"position":13,"revision_id":"a5c0f707-89f4-48ed-a454-0ae4f84f986d","resource_type":"dataset"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ca86aab-385e-4ea8-b61b-6092602ecdfc","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"59a72b83-c9a1-45d9-97e4-e6f43ab798e9","related_relationship":"","name_translated":{"fr":"Pratiques d’administration des vaccins selon le Guide canadien d’immunisation","en":"Canadian Immunization Guide's vaccine administration practice "},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Canadian Immunization Guide's vaccine administration practice ","language":["en"],"created":"2018-12-06T17:11:16.222107","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-11-november-2-2017/new-vaccine-administration-practice-recommendations-canadian-immunization-guide.html","last_modified":null,"position":14,"revision_id":"a5c0f707-89f4-48ed-a454-0ae4f84f986d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ca86aab-385e-4ea8-b61b-6092602ecdfc","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"60ce4ebd-1693-47e7-a8bc-de78bcee40b6","related_relationship":"","name_translated":{"fr":"Pratiques d’administration des vaccins selon le Guide canadien d’immunisation","en":"Canadian Immunization Guide's vaccine administration practice "},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Canadian Immunization Guide's vaccine administration practice ","language":["fr"],"created":"2018-12-06T17:11:16.222109","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-11-2-novembre-2017/nouvelles-recommandations-du-guide-canadien-immunisation-concernant-pratiques-administration-vaccins.html","last_modified":null,"position":15,"revision_id":"a5c0f707-89f4-48ed-a454-0ae4f84f986d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ca86aab-385e-4ea8-b61b-6092602ecdfc","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"018bcd21-8613-4cdb-8195-8c3452cca679","related_relationship":"","name_translated":{"fr":"Infection par le virus de l’hépatite A et le cannabis","en":"Hepatitis A virus infection and cannabis"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Hepatitis A virus infection and cannabis","language":["en"],"created":"2018-12-06T17:11:16.222112","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-11-november-2-2017/hepatitis-a-virus-infection-associated-with-cannabis-use.html","last_modified":null,"position":16,"revision_id":"a5c0f707-89f4-48ed-a454-0ae4f84f986d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ca86aab-385e-4ea8-b61b-6092602ecdfc","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"b0d27b33-0d4e-4c8b-8d8c-792d0fabf454","related_relationship":"","name_translated":{"fr":"Infection par le virus de l’hépatite A et le cannabis","en":"Hepatitis A virus infection and cannabis"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Hepatitis A virus infection and cannabis","language":["fr"],"created":"2018-12-06T17:11:16.222115","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-11-2-novembre-2017/infection-virus-hepatite-a-associee-utilisation-cannabis.html","last_modified":null,"position":17,"revision_id":"a5c0f707-89f4-48ed-a454-0ae4f84f986d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ca86aab-385e-4ea8-b61b-6092602ecdfc","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"8afb0bf5-5740-4053-8d55-b672722260cc","related_relationship":"","name_translated":{"fr":"Actualités sur les maladies infectieuses : Novembre 2017","en":"ID News: November 2017"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"ID News: November 2017","language":["en"],"created":"2018-12-06T17:11:16.222117","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-11-november-2-2017/canadian-antimicrobial-resistance-surveillance-system-2017-report-highlights.html","last_modified":null,"position":18,"revision_id":"a5c0f707-89f4-48ed-a454-0ae4f84f986d","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6ca86aab-385e-4ea8-b61b-6092602ecdfc","datastore_active":false,"id":"f64f995f-e5d9-479e-bc1d-b3c313ebc000","character_set":"","state":"active","name_translated":{"fr":"Actualités sur les maladies infectieuses : Novembre 2017","en":"ID News: November 2017"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"ID News: November 2017","language":["fr"],"created":"2018-12-06T17:11:16.222120","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-11-2-novembre-2017/systeme-canadien-surveillance-resistance-antimicrobiens-faits-saillants-rapport-2017.html","last_modified":null,"position":19,"revision_id":"a5c0f707-89f4-48ed-a454-0ae4f84f986d","resource_type":"website"}],"place_of_publication":[],"num_resources":20,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2017-11-02 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"6ca86aab-385e-4ea8-b61b-6092602ecdfc","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases. \r\n","owner_org":"1C71053B-AA64-4646-956B-41631C396018","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"CCDR: Volume 43-11, November 2, 2017: Antimicrobial resistance and One Health","revision_id":"a5c0f707-89f4-48ed-a454-0ae4f84f986d"}